The global rotator cuff repair market size was valued at USD 848.2 million in 2023 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% from 2024 to 2030. Increasing incidences of shoulder disorders, shoulder pain, weakness, and rotator cuff tendinitis are driving the market demand. Some factors directly contributing to the risk of rotator cuff injury are overuse of the shoulder joint, sporting activities, old age, and family history. According to a survey published in the National Electronic Injury Surveillance System in 2020-2021, the incidence of sporting injuries due to overuse of sports equipment has increased by 24% between 2020 and 2021. The introduction of innovative cuff rotator procedures is expected to boost surgery rates. For instance, in February 2022, UAB Orthopedics launched a subacromial balloon spacer procedure to treat rotator cuff tears.
The introduction of innovative therapies, such as novel orthobiologics, is another key driving force responsible for market growth. For instance, regenerative biologics is gaining popularity in the sports orthopedics industry. Various market players such as DePuy Synthes, Zimmer Biomet, Stryker Corporation, and Smith+Nephew are innovating their product portfolios and adopting biological therapies to enhance the patient experience. Therefore, the growing number of companies manufacturing regenerative biologics is expected to positively impact the market.
The COVID-19 pandemic created multiple challenges for global healthcare services. Many industries across the globe faced supply chain disruptions and issues with the sales of products. The pandemic negatively impacted the market growth and resulted in reduction in surgical activity to minimize nosocomial contamination. Many hospitals imposed restrictions on all non-essential surgical procedures. In March 2020, the CDC and American College of Surgeons (ACS) recommended canceling or delaying non-emergency surgical procedures. According to a study published in JSES International, the COVID-19 pandemic caused a delay of around 2 months in the rotator cuff repair procedures.
The surgical treatment segment held the largest market share in 2023. The surgical therapy includes open surgery, arthroscopy, or a combination of both. This technique helps restore the flexibility & functionality of the shoulder joint. Furthermore, growing awareness & adoption of minimally invasive surgeries owing to the benefits offered, such as reduced risk of complications, quicker recovery, and minimized post-operation complications, is driving the segment growth. Moreover, the availability of favorable reimbursement coverage policies is expected to support the segment’s growth.
On the basis of injury severity, the market is segmented into partial thickness and full thickness. Partial thickness held the largest market share in 2023 and is anticipated to register lucrative growth over the forecast period owing to the growing prevalence of osteoarthritis or bone injuries, the growing geriatric population, and increasing participation in sporting events. Partial thickness tears are commonly diagnosed in population aged 50 years & above and these tears could either be chronic or could be caused due to minor trauma. For instance, as per the NCBI estimates, the prevalence of rotator cuff injury is expected to be 22.2% in the global population.
North America dominated the market in 2023, which is attributable to well-established healthcare infrastructure, constant technological advancements, and growing healthcare expenditures. Growing collaborations between renowned companies and local players and a favorable regulatory environment are boosting the North American market. According to estimates published by The American Academy of Orthopedic Surgeons (AAOS), approximately 2 million Americans require medical care for diagnosing/treating rotator cuff disorders. The growing incidence of sporting injuries is pivotal in driving the demand for rotator cuff repair techniques. For instance, Canadians spend approximately USD 187 million annually on treating sports injuries.
The market is consolidated in nature and is composed of both international as well as regional players. Key players operating in the market are Integra Lifesciences Corporation, Smith+Nephew, Arthrex Inc., Zimmer Biomet, KARL STORZ, Stryker Corporation, Depuy Synthes, CONMED Corporation, 3S Ortho, and Breg Inc. The key players are focusing on collaborations, partnerships, and acquisitions to expand their business footprint and widen their product portfolios.
In May 2022, Embody, Inc. received U.S. FDA approval for TAPESTRY RC device. This device is used in treating rotator cuff dysfunction.
In January 2021, Stryker acquired OrthoSpcace, Ltd. Through this acquisition, the company would expand its sports medicine portfolio, inclusive of surgical products used in treating rotator cuff tears.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."